文献速递产科母胎医学生殖医学

不孕夫妇伴与不伴辅助生殖技术的妊娠与出生结局:以美国人群研究为重点

Pregnancy and birth outcomes in couples with infertility with and without assisted reproductive technology: with an emphasis on US population-based studies.
PubMed 文献 · Am J Obstet Gynecol · 2017-03-18

辅助生殖技术包括体外受精与非体外受精治疗。美国体外受精周期数2000至2013年近乎翻倍,目前1.7%活产源于该技术。多胎、供卵、冻融胚胎及不孕状态与母儿不良结局风险升高相关。

要点

  • 双胎较单胎的早产和低出生体质量风险均增加逾10倍(校正OR分别为11.84和10.68)。
  • 供卵与妊娠期高血压(校正OR 1.43)和早产(校正OR 1.43)风险升高相关。
  • 单胎中体外受精较自然生育者的严重母体并发症风险升高(阴道分娩校正OR 2.27,剖宫产校正OR 1.67)。

核心结论

  • 不孕状态无论是否接受体外受精或非体外受精不孕治疗均与母体和围产儿不良结局风险升高相关。
  • 体外受精中多胎(及相关围产儿并发症过多)的主要风险随移植胚胎数量减少和质量提高而降低。

研究设计与样本

  • 本文为以美国人群研究为重点的综述,未报告系统检索范围。

主要发现

  • 双胎较单胎的早产风险校正OR为11.84(95%CI 10.56–13.27),低出生体质量风险校正OR为10.68(95%CI 9.45–12.08)。
  • 供卵与妊娠期高血压风险升高相关(校正OR 1.43,95%CI 1.14–1.78),与早产风险升高相关(校正OR 1.43,95%CI 1.11–1.83)。
  • 冻融胚胎与妊娠期高血压风险升高相关(校正OR 1.30,95%CI 1.08–1.57),与大于胎龄儿出生体质量风险升高相关(校正OR 1.74,95%CI 1.45–2.08)。
  • 单胎中体外受精较自然生育者严重母体并发症风险升高:阴道分娩校正OR 2.27(95%CI 1.78–2.88),剖宫产校正OR 1.67(95%CI 1.40–1.98)。
  • 单胎中体外受精较低生育力分娩者严重母体并发症风险升高:阴道分娩校正OR 1.97(95%CI 1.30–3.00),剖宫产校正OR 1.75(95%CI 1.30–2.35);双胎中剖宫产体外受精分娩较剖宫产自然生育者严重母体并发症风险升高(校正OR 1.48,95%CI 1.14–1.93)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Infertility, defined as the inability to conceive within 1 year of unprotected intercourse, affects an estimated 80 million individuals worldwide, or 10-15% of couples of reproductive age. Assisted reproductive technology includes all infertility treatments to achieve conception; in vitro fertilization is the process by which an oocyte is fertilized by semen outside the body; non-in vitro fertilization assisted reproductive technology treatments include ovulation induction, artificial insemination, and intrauterine insemination. Use of assisted reproductive technology has risen steadily in the United States during the past 2 decades due to several reasons, including childbearing at older maternal ages and increasing insurance coverage. The number of in vitro fertilization cycles in the United States has nearly doubled from 2000 through 2013 and currently 1.7% of all live births in the United States are the result of this technology. Since the birth of the first child from in vitro fertilization >35 years ago, >5 million babies have been born from in vitro fertilization, half within the past 6 years. It is estimated that 1% of singletons, 19% of twins, and 25% of triplet or higher multiples are due to in vitro fertilization, and 4%, 21%, and 52%, respectively, are due to non-in vitro fertilization assisted reproductive technology. Higher plurality at birth results in a >10-fold increase in the risks for prematurity and low birthweight in twins vs singletons (adjusted odds ratio, 11.84; 95% confidence interval, 10.56-13.27 and adjusted odds ratio, 10.68; 95% confidence interval, 9.45-12.08, respectively). The use of donor oocytes is associated with increased risks for pregnancy-induced hypertension (adjusted odds ratio, 1.43; 95% confidence interval, 1.14-1.78) and prematurity (adjusted odds ratio, 1.43; 95% confidence interval, 1.11-1.83). The use of thawed embryos is associated with higher risks for pregnancy-induced hypertension (adjusted odds ratio, 1.30; 95% confidence interval, 1.08-1.57) and large-for-gestation birthweight (adjusted odds ratio, 1.74; 95% confidence interval, 1.45-2.08). Among singletons, in vitro fertilization is associated with increased risk of severe maternal morbidity compared with fertile deliveries (vaginal: adjusted odds ratio, 2.27; 95% confidence interval, 1.78-2.88; cesarean: adjusted odds ratio, 1.67; 95% confidence interval, 1.40-1.98, respectively) and subfertile deliveries (vaginal: adjusted odds ratio, 1.97; 95% confidence interval, 1.30-3.00; cesarean: adjusted odds ratio, 1.75; 95% confidence interval, 1.30-2.35, respectively). Among twins, cesarean in vitro fertilization deliveries have significantly greater severe maternal morbidity compared to cesarean fertile deliveries (adjusted odds ratio, 1.48; 95% confidence interval, 1.14-1.93). Subfertility, with or without in vitro fertilization or non-in vitro fertilization infertility treatments to achieve a pregnancy, is associated with increased risks of adverse maternal and perinatal outcomes. The major risk from in vitro fertilization treatments of multiple births (and the associated excess of perinatal morbidity) has been reduced over time, with fewer and better-quality embryos being transferred.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Luke B. Pregnancy and birth outcomes in couples with infertility with and without assisted reproductive technology: with an emphasis on US population-based studies. Am J Obstet Gynecol. 2017. PMID: 28322775. doi:10.1016/j.ajog.2017.03.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。